Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies: Erratum
- PMID: 31714407
- PMCID: PMC7566290
- DOI: 10.1097/ICO.0000000000002221
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies: Erratum
Erratum for
-
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.Cornea. 2019 Oct;38(10):1259-1265. doi: 10.1097/ICO.0000000000001989. Cornea. 2019. PMID: 31306284 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources